Novo Nordisk
Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd. Novo Nordisk is controlled by majority shareholder Novo Holdings A/S which holds approximately 28.1% of its shares and a majority (77.1%) of its voting shares.
How Novo Nordisk is moving across the news
Novo Nordisk faces a bifurcated outlook: robust growth drivers in obesity and longevity markets (Wegovy adoption, European expansion) are offset by cyberattack risks and competitive threats from Pfizer/Eli Lilly. Short-term volatility may persist despite long-term operational moats.
Recent news mentioning Novo Nordisk
Appears alongside
See Novo Nordisk's full profile, network and analytical read on Beyond →